Aqua Bio Technology ASA (Oslo Axess: ABT) has revised the previously announced financial calendar for 2012.
ABT's scheduled corporate events are on these dates:
Q4 2011 results: 17. February 2012
Q1 2012 results: 23. May 2012
AGM 2012: 14. June 2012
Q2 2012 results: 28. August 2012
Q3 2012 results: 27. November 2012
Q4 2012 results: 13. February 2013
For further information, please call Arvid Lindberg, CEO, telephone +47 9824 5410
Aqua Bio Technology ASA (ABT) develops, produces and markets patented ingredients and technologies to the international cosmetic and skin care industry. ABT's lead ingredient Aquabeautine XL® is a patented marine solution derived from the hatching fluid of salmon. The ingredient adds moisture and improves the renewal of skin cells in an effective and gentle manner, providing anti-aging effects. ABT is listed on the Oslo Stock Exchange's Axess market.
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
